9R9-77219-60778
2 vaccinations
5 coded responses
7 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 950 / CA
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Pfizer-BioNTech
-
2021-03-05
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-03-06
Survey response — days 1–6 daily, dose 1MedDRA: Gastrooesophageal reflux disease, Injection site pain, Nausea, Oropharyngeal pain — Feeling: GoodFree text: 1. Feeling of sore throat, possibly caused by acid reflux (had some nausea before acid reflux). 2. Mild soreness at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2021-04-02
Survey response — day 0, dose 2MedDRA: Decreased appetite, Dysgeusia, Nasal congestion — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: loss of appetite, nasal congestion, bitter taste on tongueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Dysgeusia, Dyspepsia, Eructation, Injection site pain — Feeling: Fair · Fatigue or tiredness, NauseaFree text: soreness at injection site (mild to moderate), limited appetite, heartburn, some belching, bitter taste on tongue (last 3 symptoms most likely connected to acid reflux).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · NauseaFree text: somewhat limited appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Dyspepsia, Oropharyngeal pain — Feeling: Good · NauseaFree text: heartburn (mild), sore throat feeling (may be from acid reflux)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): 1. Feeling of sore throat, possibly caused by acid reflux (had some nausea before acid reflux). 2. Mild soreness at injection site.
Release 6 — day 0, dose 2
Systemic reaction (other): loss of appetite, nasal congestion, bitter taste on tongue
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): soreness at injection site (mild to moderate), limited appetite, heartburn, some belching, bitter taste on tongue (last 3 symptoms most likely connected to acid reflux).
Systemic reaction (other): somewhat limited appetite
Systemic reaction (other): heartburn (mild), sore throat feeling (may be from acid reflux)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Dyspepsia | ✓ | ✓ | ✓ |
| SRO | Eructation | ✓ | ✓ | ✓ |
| SRO | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release